Kazia Therapeutics Limited (NASDAQ: KZIA) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT KAZIA THERAPEUTICS LIMITED

Kazia Therapeutics Limited (NASDAQ: KZIA)
Listen to this Section


$1.38
-0.0200 ( -0.72% ) 327.0K

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.

Market Data


Open $1.38
Previous Close $1.40
Volume 327.0K
Market Cap $7.83M
Day Range $1.32 - $1.47
52 Week Range $1.32 - $15.80
Shares Outstanding 5.59M
Change % -0.72%
Net Change ▼ -0.0200
Insider Ownership N/A
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 1999
Country Australia

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
424b3 Other 3 Dec 11, 2024
424b3 Other 3 Dec 11, 2024
6-k Form 6-K 3 Dec 11, 2024
424b3 Other 2 Dec 03, 2024
424b3 Other 2 Dec 03, 2024
effect Other 1 Dec 02, 2024
effect Other 1 Dec 02, 2024
pos Registration statements 4 Nov 27, 2024
pos Registration statements 4 Nov 27, 2024
20-f Annual reports 145 Nov 15, 2024

Latest News


× Before browsing our site, please accept our cookies policy